Novavax, Inc. (NVAX): Price and Financial Metrics
NVAX Price/Volume Stats
| Current price | $7.45 | 52-week high | $19.50 |
| Prev. close | $6.99 | 52-week low | $5.01 |
| Day low | $7.02 | Volume | 7,397,368 |
| Day high | $7.48 | Avg. volume | 6,897,932 |
| 50-day MA | $6.61 | Dividend yield | N/A |
| 200-day MA | $8.91 | Market Cap | 1.21B |
NVAX Stock Price Chart Interactive Chart >
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
NVAX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NVAX Price Returns
| 1-mo | 25.21% |
| 3-mo | -10.67% |
| 6-mo | -16.67% |
| 1-year | -61.90% |
| 3-year | N/A |
| 5-year | -83.91% |
| YTD | -7.34% |
| 2024 | 67.50% |
| 2023 | -53.31% |
| 2022 | -92.81% |
| 2021 | 28.30% |
| 2020 | 2,701.76% |